A Double Blind Study for the Treatment of Acute Ulcerative Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

772

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Ulcerative Colitis
Interventions
DRUG

Mesalamine

"Asacol 400g/day (400 mg tablet), oral, for 6 weeks~OR~Asacol 4,8 g/day (800 mg table), oral, for 6 weeks"

Trial Locations (135)

98

Research Facility, Nagyerdei Krt

5067

Research Facility, San Juan

10000

Research Facility, Zagreb

10021

Research Facility, New York

10138

Research Facility, Tallinn

11021

Research Facility, Great Neck

11080

Research Facility, Belgrade

11530

Research Facility, Garden City

11743

Research Facility, Huntington

12180

Research Facility, Troy

13903

Research Facility, Binghamton

14642

Research Facility, Rochester

15010

Research Facility, Beaver Falls

17403

Research Facility, York

19107

Research Facility, Philadelphia

20815

Research Facility, Chevy Chase

21000

Research Facility, Novi Sad

21136

Research Facility, Reisterstown

21215

Research Facility, Baltimore

23320

Research Facility, Chesapeake

28262

Research Facility, Charlotte

28401

Research Facility, Wilmington

29203

Research Facility, Columbia

30033

Research Facility, Atlanta

31405

Research Facility, Savannah

32256

Research Facility, Jacksonville

32720

Research Facility, DeLand

33021

Research Facility, Hollywood

33405

Research Facility, Panama City

33542

Research Facility, Zephyrhills

34684

Research Facility, Harbor Village

35007

Research Facility, Alabaster

35209

Research Facility, Birmingham

37232

Research Facility, Nashville

37660

Research Facility, Kingsport

38120

Research Facility, Memphis

38801

Research Facility, Tupelo

40292

Research Facility, Louisville

44302

Research Facility, Akron

44484

Research Facility, Warren

45242

Research Facility, Cincinnati

45440

Research Facility, Dayton

51000

Research Facility, Rijeka

51014

Research Facility, Tartu

53215

Research Facility, Milwaukee

55455

Research Facility, Minneapolis

55905

Research Facility, Rochester

58104

Research Facility, Fargo

60005

Research Facility, Arlington Heights

60606

Research Facility, Topeka

60637

Research Facility, Chicago

61037

Research Facility, Kharkiv

63128

Research Facility, St Louis

64131

Research Facility, Kansas City

65025

Research Facility, Zabolotnogo

65212

Research Facility, Columbia

68131

Research Facility, Omaha

69050

Research Facility, Zaporizhzhya

69361

Research Facility, Scottsbluff

70809

Research Facility, Baton Rouge

71103

Research Facility, Shreveport

72205

Research Facility, Little Rock

72703

Research Facility, Fayetteville

78205

Research Facility, San Antonio

78743

Research Facility, Austin

80120

Research Facility, Littleton

80215

Research Facility, Lakewood

84107

Research Facility, Murray

84405

Research Facility, Ogden

85712

Research Facility, Tucson

90067

Research Facility, Los Angeles

90274

Research Facility, Los Angeles

91105

Research Facility, Pasadena

91345

Research Facility, Mission Hills

91505

Research Facility, Burbank

92801

Research Facility, Anaheim

92868

Research Facility, Orange

93024

Research Facility, Encinitas

94070

Research Facility, San Carlos

94115

Research Facility, San Francisco

95000

Research Facility, Simpheropol

95661

Research Facility, Roseville

95825

Research Facility, Sacramento

97220

Research Facility, Portland

98052

Research Facility, Redmond

129110

Research Facility, Moscow

196247

Research Facility, Saint Petersburg

210037

Research Facility, Vitebsk

220013

Research Facility, Minsk

230017

Research Facility, Hrodna

400162

Research Facility, Cluj-Napoca

603126

Research Facility, Nizhny Novgorod

700111

Research Facility, Iași

06518-3691

Research Facility, Hamden

02115

Research Facility, Boston

08234

Research Facility, Egg Harbor

58501-1640

Research Facility, Bismarck

05401

Research Facility, Burlington

Unknown

Research Facility, Gornel

Research Facility, Pavlov

Research Facility, Budapest

T6G 2X8

Research Facility, Edmonton

V2S 3N5

Research Facility, Abbotsford

V5Z 112

Research Facility, Vancouver

N1H 3R3

Research Facility, Guelph

L8N 3Z5

Research Facility, Hamilton

N6A 5K8

Research Facility, London

K1H 8L6

Research Facility, Ottawa

M3N 2V7

Research Facility, Toronto

G6V 3Z1

Research Facility, Lévis

J4N 1E1

Research Facility, Longheuil

H31 1E2

Research Facility, Montreal

G1L 3L5

Research Facility, Québec

G1R 2J6

Research Facility, Québec

G5L 5T1

Research Facility, Rimouski

S7K 1N4

Research Facility, Saskatoon

500 12

Research Facility, Kralove

120 00

Research Facility, Prague

3886 29

Research Facility, Strakonice

401 13

Research Facility, Ústí nad Labem

1-3

Research Facility, Argenti Dome Ter

LV-1002

Research Facility, Riga

LT-50009

Research Facility, Kaunas

LT-35144

Research FacilityPanevezys, Panevezys

LT-08661

Research Facility, Santariskiu

85-681

Research Facility, Bydgoszcz

42-200

Research Facility, Częstochowa

31-501

Research Facility, Krakow

05-800

Research Facility, Pruszków

81-756

Research Facility, Sopot

02-57

Research Facility, Warsaw

87-800

Research Facility, Wtoctawek

90-153

Research Facility, Lodz

010825

Research Facility, Bucharest

04053

Research Facility, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT00350415 - A Double Blind Study for the Treatment of Acute Ulcerative Colitis | Biotech Hunter | Biotech Hunter